Alzheimer's Disease and Dementia
Medicare Coverage of Aducanumab for Alzheimer Disease: The Impact of the Decision
- Higher Daily Step Count and Intensity Optimal for Reducing Dementia Risk
- Could Low-Dose Ketamine Be a Treatment for ADNP Syndrome in Children?
- Vascular Health Associated With Migraine Risk Among Adult Women
- Veterans With IBS Experience Psychological Comorbidities, High Health Care Use
- Acetaminophen Exposure in Utero Tied to Child Neurobehavioral Problems
- Deep Brain Stimulation May Ease Symptoms of Severe OCD
- Migraine May Increase Subsequent Dementia Risk
- COVID-19 Pandemic Tied to Burnout in Health Care Professionals
- Vamorolone May Be a Safer Treatment for Duchenne Muscular Dystrophy in Boys
- Novel Therapeutic Approach Improves Episodic Memory in Alzheimer Disease
- Children With ADHD Do Not Show Reduced Dual-Task Performance
- FibroLux Laser Therapy Cleared to Treat Pain Associated With Fibromyalgia
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
Neoadjuvant Nivolumab-Ipilimumab Could Be New Standard Care in dMMR Colon Cancer
Sense of Coherence Predicts Psychopathological Symptoms During COVID-19 Pandemic
Corticosteroid Dose Predicts Mortality in Rheumatic Diseases Plus Pneumonia
Opioid Prescription Trends Show Decline in Use for Cancer, Noncancer Pain
Enfortumab Vedotin Plus Pembrolizumab ‘Promising’ for Untreated Advanced Urothelial Carcinoma
